Global clinical supplier Xerimis opens depot in Amsterdam
US-headquartered Xerimis specialises in helping pharmaceutical companies conduct global, multi-continent clinical studies by providing packaging and storage facilities.
Xerimis opens new warehouse near Schiphol
The US company provides customised clinical packaging services for international pharmaceutical, biotechnology and clinical research organisations.
This includes the entire clinical development chain, from labelling and packaging to temperature-controlled storage, to support multi-country clinical trials.
Alongside depots in the US and UK, its new Amsterdam site will increase its storage and service capabilities for clients on the continent, as well as overcome potential challenges presented by Brexit.
In a press statement, the company also announced expansions at its global headquarters in New Jersey. Jim LoCascio, Vice President, Global Business and Strategic Development, said: “These monumental additions come on the heels of several years of growth for our company, and we remain thankful for the journey that has brought us here.”
Where life sciences meets logistics
As a global hub for the life sciences industry, Amsterdam has an excellent infrastructure for the import and export of pharmaceuticals. Many leading pharma companies are based in Amsterdam so they can easily distribute their products via Schiphol, which has a specialised pharma zone. Among them are cancer treatment developer Kite Pharma, pharma products distributor Nippon Express and medical devices firm Specific Diagnostics.
The Dutch capital’s central location puts more than 500 million consumers across Europe within easy reach, and there are roughly 400 logistics and transportation companies working in the region.